In humans and murine models of PCM, resistance to disease is associated with the secretion of IFN-γ and other Th1 cytokines, whereas impaired Th1 immunity and the prevalent secretion of Th2 cytokines correlate with systemic and progressive disease [1–3]. This evidence concerns the gene IFNG and paracoccidioidomycosis.